Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste.
Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste.
复制标题
DOI:
10.1136/bmj.b4248
复制
发表时间:
2009-10-26
期刊:
影响因子:
--
通讯作者:
Kelly PM
中科院分区:
文献类型:
--
作者:
Martins N;Morris P;Kelly PM
Objective To determine the effectiveness of the provision of whole food to enhance completion of treatment for tuberculosis. Design Parallel group randomised controlled trial. Setting Three primary care clinics in Dili, Timor-Leste. Participants 270 adults aged ≥18 with previously untreated newly diagnosed pulmonary tuberculosis. Main outcome measures Completion of treatment (including cure). Secondary outcomes included adherence to treatment, weight gain, and clearance of sputum smears. Outcomes were assessed remotely, blinded to allocation status. Interventions Participants started standard tuberculosis treatment and were randomly assigned to intervention (nutritious, culturally appropriate daily meal (weeks 1-8) and food package (weeks 9-32) (n=137) or control (nutritional advice, n=133) groups. Randomisation sequence was computer generated with allocation concealment by sequentially numbered, opaque, sealed envelopes. Results Most patients with tuberculosis were poor, malnourished men living close to the clinics; 265/270 (98%) contributed to the analysis. The intervention had no significant beneficial or harmful impact on the outcome of treatment (76% v 78% completion, P=0.7) or adherence (93% for both groups, P=0.7) but did lead to improved weight gain at the end of treatment (10.1% v 7.5% improvement, P=0.04). Itch was more common in the intervention group (21% v 9%, P<0.01). In a subgroup analysis of patients with positive results on sputum smears, there were clinically important improvements in one month sputum clearance (85% v 67%, P=0.13) and completion of treatment (78% v 68%, P=0.3). Conclusion Provision of food did not improve outcomes with tuberculosis treatment in these patients in Timor-Leste. Further studies in different settings and measuring different outcomes are required. Trial registration Clinical Trials NCT0019256.
登录
查看更多内容
影响因子:
4.2
作者:
Karyadi, E;Schultink, W;West, CE
通讯作者:
West, CE
影响因子:
3.3
作者:
Range, N;Andersen, ÅB;Friis, H
通讯作者:
Friis, H
影响因子:
7.1
作者:
Paton, NI;Chua, YK;Chee, CB
通讯作者:
Chee, CB
影响因子:
5.1
作者:
Hanekom, WA;Potgieter, S;Hussey, GD
通讯作者:
Hussey, GD
影响因子:
3.7
作者:
van Lettow, M;Harries, AD;Semba, RD
通讯作者:
Semba, RD